Minimal Invasive Surgery for Gastric Subepithelial Tumor

Gastric Subepithelial Tumor Clinical Trial

Official title:

Different Approach of Minimal Invasive Surgery for Gastric Subepithelial Tumor From A Single-Center Experience

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05452265
• Other study ID #: 220117
• Status: Completed
• Start date: January 1, 2013
• Est. completion date: December 31, 2021

Study information

• Verified date: July 2022
• Source: Changhua Christian Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators conducted a retrospective study of those patients with gastric SETs receiving ER or LR at the operative theater in the single institution from January 2013 to December 2021. Medical records were retrospectively reviewed to define patient/tumor characteristics and operative outcomes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 194
• Est. completion date: December 31, 2021
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• patients with gastric subepithelial tumors

• patients received minimal invasive surgery (endoscopy or laparoscopy) for tumor resection

Exclusion Criteria:

• patients had gastric anatomic changes due to previous surgery

• patients converted open surgery

Related Conditions & MeSH terms

• Gastric Subepithelial Tumor
• Neoplasms

Intervention

Procedure:
• Endoscopic resection
Complete resection of gastric SETs was recommended if the tumor size was >2 cm, presence of malignant features, or if the patient was symptomatic, declined periodical surveillance, and preferred to undergo diagnostic and therapeutic resection.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Changhua Christian Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Procedure duration	minutes of procedure time	during the procedure/surgery
Primary	Length of hospital stay	days of hospitalization	upto one month after surgery
Primary	Rate of postoperative major complications	complications required further intervention, clavien dindo classification upto Grade III	upto one month after surgery